In addition to VHL pathway abnormalities, non‐ccRCC subtypes may also harbor mutations in other genes such as CDKN2A, PTEN, NRF2, TP53, TFE3, TFEB, and SMARCB1.2 This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.